The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mehta Vimal since 2018.
This trader's CIK number is 1733369.
At the time of last reporting, Mehta Vimal was the CEO and President of Bioxcel Therapeutics, Inc.. (stock ticker symbol BTAI).
Also see all insider trading activities at Bioxcel Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BTAI | 0 | $0 | 0 | $0 | 761 | $0 |
| 2024 | BTAI | 0 | $0 | 12,501 | $19,050 | 34,938 | $0 |
| 2023 | BTAI | 0 | $0 | 131,000 | $2,682,661 | 153,265 | $49,200 |
| 2022 | BTAI | 0 | $0 | 60,000 | $1,187,700 | 60,000 | $24,600 |
| 2021 | BTAI | 0 | $0 | 473,250 | $14,589,351 | 0 | $0 |
| 2019 | BTAI | 4,957 | $43,187 | 0 | $0 | 0 | $0 |
| 2018 | BTAI | 5,000 | $24,209 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-15 | BTAI | Option Ex | 219 | .00 | 0 |
| 2025-06-14 | BTAI | Option Ex | 163 | .00 | 0 |
| 2025-03-14 | BTAI | Option Ex | 162 | .00 | 0 |
| 2025-03-15 | BTAI | Option Ex | 217 | .00 | 0 |
| 2024-12-16 | BTAI | Sale | 3,117 | .36 | 1,131 |
| 2024-12-15 | BTAI | Option Ex | 3,500 | .00 | 0 |
| 2024-12-14 | BTAI | Option Ex | 2,610 | .00 | 0 |
| 2024-09-15 | BTAI | Option Ex | 3,500 | .00 | 0 |
| 2024-09-16 | BTAI | Sale | 1,982 | .69 | 1,367 |
| 2024-09-14 | BTAI | Option Ex | 2,609 | .00 | 0 |
| 2024-06-17 | BTAI | Sale | 2,134 | 1.28 | 2,740 |
| 2024-06-15 | BTAI | Option Ex | 3,500 | .00 | 0 |
| 2024-06-14 | BTAI | Option Ex | 2,609 | .00 | 0 |
| 2024-03-14 | BTAI | Option Ex | 2,610 | .00 | 0 |
| 2024-03-15 | BTAI | Option Ex | 14,000 | .00 | 0 |
| 2024-04-04 | BTAI | Sale | 5,268 | 2.62 | 13,812 |
| 2023-12-14 | BTAI | Option Ex | 2,609 | .00 | 0 |
| 2023-09-14 | BTAI | Option Ex | 2,610 | .00 | 0 |
| 2023-06-14 | BTAI | Option Ex | 2,609 | .00 | 0 |
| 2023-06-15 | BTAI | Option Ex | 30,000 | .41 | 12,300 |
| 2023-06-16 | BTAI | Option Ex | 30,000 | .41 | 12,300 |
| 2023-06-15 | BTAI | Sale | 30,000 | 21.66 | 649,650 |
| 2023-06-16 | BTAI | Sale | 30,000 | 20.93 | 627,990 |
| 2023-05-22 | BTAI | Sale | 6,500 | 25.79 | 167,641 |
| 2023-05-14 | BTAI | Option Ex | 15,000 | .00 | 0 |
| 2023-03-21 | BTAI | Sale | 30,000 | 19.93 | 597,750 |
| 2023-03-20 | BTAI | Sale | 34,500 | 18.54 | 639,630 |
| 2023-03-21 | BTAI | Option Ex | 30,000 | .41 | 12,300 |
| 2023-03-20 | BTAI | Option Ex | 30,000 | .41 | 12,300 |
| 2023-03-14 | BTAI | Option Ex | 10,437 | .00 | 0 |
| 2022-12-16 | BTAI | Sale | 30,000 | 19.57 | 586,950 |
| 2022-12-15 | BTAI | Sale | 30,000 | 20.02 | 600,750 |
| 2022-12-16 | BTAI | Option Ex | 30,000 | .41 | 12,300 |
| 2022-12-15 | BTAI | Option Ex | 30,000 | .41 | 12,300 |
| 2021-06-25 | BTAI | Sale | 473,250 | 30.83 | 14,589,351 |
| 2019-08-16 | BTAI | Buy | 974 | 8.89 | 8,658 |
| 2019-08-15 | BTAI | Buy | 2,625 | 8.67 | 22,758 |
| 2019-08-14 | BTAI | Buy | 358 | 8.44 | 3,021 |
| 2019-08-13 | BTAI | Buy | 1,000 | 8.75 | 8,750 |
| 2018-12-14 | BTAI | Buy | 2,000 | 4.41 | 8,824 |
| 2018-12-04 | BTAI | Buy | 1,000 | 5.12 | 5,120 |
| 2018-12-03 | BTAI | Buy | 1,000 | 5.15 | 5,150 |
| 2018-11-30 | BTAI | Buy | 1,000 | 5.12 | 5,115 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mehta Vimal (CEO and President of Bioxcel Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.